Immunological memory to SARS‐CoV‐2 infection and COVID‐19 vaccines

A Sette, S Crotty - Immunological reviews, 2022 - Wiley Online Library
Immunological memory is the basis of protective immunity provided by vaccines and
previous infections. Immunological memory can develop from multiple branches of the …

T cell responses to SARS-CoV-2

A Sette, J Sidney, S Crotty - Annual review of immunology, 2023 - annualreviews.org
A large body of evidence generated in the last two and a half years addresses the roles of T
cells in SARS-CoV-2 infection and following vaccination. Infection or vaccination induces …

Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study

L Wieske, KPJ van Dam, M Steenhuis… - The Lancet …, 2022 - thelancet.com
Background Disease-specific studies have reported impaired humoral responses after
SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders treated …

Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis

A Grifoni, T Alonzi, G Alter, DMC Noonan… - Frontiers in …, 2023 - frontiersin.org
Knowledge of aging biology needs to be expanded due to the continuously growing number
of elderly people worldwide. Aging induces changes that affect all systems of the body. The …

Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in …

MP Sormani, I Schiavetti, M Inglese, L Carmisciano… - …, 2022 - thelancet.com
Background In this study we aimed to monitor the risk of breakthrough SARS-CoV-2
infection in patients with MS (pwMS) under different DMTs and to identify correlates of …

Vaccination and immunotherapies in neuroimmunological diseases

A Winkelmann, M Loebermann, M Barnett… - Nature Reviews …, 2022 - nature.com
Neuroimmunological diseases and their treatment compromise the immune system, thereby
increasing the risk of infections and serious illness. Consequently, vaccinations to protect …

Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis

X Wu, L Wang, L Shen, K Tang - EBioMedicine, 2022 - thelancet.com
Background COVID-19 vaccination is recommended for patients with multiple sclerosis
(pwMS), while disease-modifying therapies (DMTs) may influence the efficacy of SARS-CoV …

Kinetics of the B-and T-cell immune responses after 6 months from SARS-CoV-2 mRNA vaccination in patients with rheumatoid arthritis

C Farroni, A Picchianti-Diamanti, A Aiello… - Frontiers in …, 2022 - frontiersin.org
Objective To assess the kinetics of the humoral and cell-mediated responses after severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in rheumatoid arthritis …

[HTML][HTML] Neutralizing antibody response against the B. 1.617. 2 (delta) and the B. 1.1. 529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney …

L Benning, C Morath, M Bartenschlager, H Kim… - American Journal of …, 2022 - Elsevier
Seroconversion after COVID-19 vaccination is impaired in kidney transplant recipients.
Emerging variants of concern such as the B. 1.617. 2 (delta) and the B. 1.1. 529 (omicron) …

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial

D Mrak, D Sieghart, E Simader, S Tobudic… - Nature …, 2022 - nature.com
Impaired response to COVID-19 vaccination is of particular concern in immunosuppressed
patients. To determine the best vaccination strategy for this vulnerable group we performed …